Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Lieberman

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|October 11, 2002
Defying death--HIV mutation to evade cytotoxic T lymphocytesJudy Lieberman
The New England Journal of Medicine|October 9, 2009
Micromanaging cancerJudy Lieberman
Immunological Reviews|June 12, 2010
Anatomy of a murder: how cytotoxic T cells and NK cells are activated, develop, and eliminate their targetsJudy Lieberman
Nature Reviews. Immunology|May 27, 2003
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenalJudy Lieberman
AIDS (London, England)|July 9, 2004
Tracking the killers: how should we measure CD8 T cells in HIV infection?Judy Lieberman
Nature Structural & Molecular Biology|April 18, 2018
Tapping the RNA world for therapeuticsJudy Lieberman
Immunological Reviews|June 12, 2010
Granzyme A activates another way to dieJudy Lieberman
Current Opinion in Immunology|July 8, 2015
Manipulating the in vivo immune response by targeted gene knockdownJudy Lieberman
The New England Journal of Medicine|September 12, 2018
Unveiling the RNA WorldJudy Lieberman
Plos One|July 16, 2015
miR-34 and p53: New Insights into a Complex Functional RelationshipFrancisco Navarro, Judy Lieberman
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|October 11, 2002
Defying death--HIV mutation to evade cytotoxic T lymphocytesJudy Lieberman
The New England Journal of Medicine|October 9, 2009
Micromanaging cancerJudy Lieberman
Immunological Reviews|June 12, 2010
Anatomy of a murder: how cytotoxic T cells and NK cells are activated, develop, and eliminate their targetsJudy Lieberman
Nature Reviews. Immunology|May 27, 2003
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenalJudy Lieberman
AIDS (London, England)|July 9, 2004
Tracking the killers: how should we measure CD8 T cells in HIV infection?Judy Lieberman
Nature Structural & Molecular Biology|April 18, 2018
Tapping the RNA world for therapeuticsJudy Lieberman
Immunological Reviews|June 12, 2010
Granzyme A activates another way to dieJudy Lieberman
Current Opinion in Immunology|July 8, 2015
Manipulating the in vivo immune response by targeted gene knockdownJudy Lieberman
The New England Journal of Medicine|September 12, 2018
Unveiling the RNA WorldJudy Lieberman
Plos One|July 16, 2015
miR-34 and p53: New Insights into a Complex Functional RelationshipFrancisco Navarro, Judy Lieberman
Pageof 22